Ripple Therapeutics
Description: The Ripple Therapeutics' Epidel technology is founded on a discovery that drugs can be engineered into controlled release Pharmaceuticals and Medical Device Coatings without the use of polymers or excipients. Our lead product (IBE-814 IVT) is a fully degradable intravitreal dexamethasone prodrug implant targeting DME, RVO and NIU indications.
glaucoma (485) nanoparticles (59) microparticles (9) new chemical entity (5) ripple therapeutics (2) epidel (2) intravitreal implants (2) medical device coatings (2) proprietary prodrug (2) ibe-814 ivt (2)
MaRS Center, South Tower
101 College Street, Suite 300
Toronto, ON, M5G 1L7
Ripple Therapeutics